Protein fragment complementation assays for the detection of biological or drug interactions

• US 6,428,951 B1
• Filed: 02/07/2000
• Issued: 08/06/2002
• Est. Priority Date: 01/31/1997
• Status: Expired due to Term

• Current Assignee: Odyssey Thera, Inc.
• Original Assignee: Odyssey Pharmaceuticals, Inc.
• Inventors: Michnick, Stephen William Watson, Remy, Ingrid, Pelletier, Joelle Nina
• Primary Examiner(s): Brusca, John S.
• Application Number:
  US09/499,464
• Time in Patent Office: 911 Days
• Field of Search: 435/4, 435/6, 530/350, 536/23.2, 536/23.4
• US Class Current: 435/4
• CPC Class Codes: A01K 2267/0331 Animal model for proliferative diseases
• CPC Class Codes: A01K 2267/0393 Animal model comprising a reporter system for screening tests
• CPC Class Codes: A01K 67/0271 Chimeric vertebrates, e.g. comprising exogenous cells
• CPC Class Codes: C07K 14/43595 from coelenteratae, e.g. medusae
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: C12N 15/1055 Protein x Protein interaction, e.g. two hybrid selection
• CPC Class Codes: G01N 33/5008 for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
• CPC Class Codes: G01N 33/542 with steric inhibition or signal modification, e.g. fluorescent quenching
• CPC Class Codes: G01N 33/573 for enzymes or isoenzymes
• CPC Class Codes: G01N 33/58 involving labelled substances G01N33/53 takes precedence
• CPC Class Codes: G01N 33/581 with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
• CPC Class Codes: G01N 33/68 involving proteins, peptides or amino acids involving lipoproteins G01N33/92
• CPC Class Codes: G01N 33/6803 General methods of protein analysis not limited to specific proteins or families of proteins
• CPC Class Codes: G01N 33/6845 Methods of identifying protein-protein interactions in protein mixtures
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

We describe a strategy for designing and implementing protein-fragment complementation assays (PCAs) to detect biomolecular interactions in vivo and in vitro. The design, implementation and broad applications of this strategy are illustrated with a large number of enzymes with particular detail provided for the example of murine dihydrofolate reductase (DHFR). Fusion peptides consisting of N- and C-terminal fragments of murine DHFR fused to-GCN4 leucine zipper sequences were coexpressed in Escherichia coli grown in minimal medium, where the endogenous DHFR activity was inhibited with trimethoprim. Coexpression of the complementary fusion products restored colony formation. Survival only occurred when both DHFR fragments were present and contained leucine-zipper forming sequences, demonstrating that reconstitution of enzyme activity requires assistance of leucine zipper formation. DHFR fragment-interface point mutants of increasing severity (lie to Val, Ala and Gly) resulted in a sequential increase in E. coli doubling times illustrating the successful DHFR fragment reassembly rather than non-specific interactions between fragments. This assay could be used to study equilibrium and kinetic aspects of molecular interactions including protein-protein, protein-DNA, protein-RNA, protein-carbohydrate and protein-small molecule interactions, for screening cDNA libraries for binding of a target protein with unknown proteins or libraries of small organic molecules for biological activity. The selection and design criteria applied here is developed for numerous examples of clonal selection, colorometric, fluorometric and other assays based on enzymes whose products can be measured. The development of such assay systems is shown to be simple, and provides for a diverse set of protein fragment complementation applications.

Claims

1. Protein fragment complementation assays for the detection of molecular interactions comprising a reassembly of separate fragments of a monomeric enzyme wherein reassembly of the monomeric enzyme fragments is operated by the interaction of molecular domains fused to each monomeric enzyme fragment, wherein reassembly of the monomeric enzyme fragments is independent of other molecular processes and wherein said reassembly is detected by means of reconstitution of activity of said enzyme.

15. The assay of claim 1 which comprises using a composition comprising complementary fragments of a first monomeric enzyme molecule, each fused to a separate molecule.

16. An assay according to claim 1 which comprises using a composition comprising a product selected from the group consisting of:

(a) a first fusion product comprising;

1) a first fragment of a monomeric enzyme molecule whose fragments can exhibit a detectable activity when associated and

2) a first protein-protein interacting domain;

(b) a second fusion product comprising

1) a second fragment of said first monomeric enzyme molecule and

2) a second protein-protein interacting domain that can bind said first protein-protein interacting domain; and

(c) both (a) and (b).

17. A method of detecting kinetics of protein assembly comprising the method of any one of claims 1, 2, 3, 4 or 8 wherein time dependent reconstitution of enzyme activity is the detecting means.

18. A method according to any one of claims 1, 2, 3, 4, 8, or 11 wherein a chromogenic, fluorogenic, enzymatic, cell survival assay or other detectable signal is generated.

2. A method for detecting biomolecular interactions said method comprising:

(a) selecting an appropriate monomeric enzyme reporter molecule;

(b) effecting fragmentation of said monomeric enzyme reporter molecule such that said fragmentation results in reversible loss of reporter function;

(c) fusing or attaching fragments of said monomeric enzyme reporter molecule separately to other molecules;

(d) reassociating said monomeric enzyme reporter fragments through interactions of the molecules that are fused or attached to said fragments; and

(e) detecting the activity of said enzyme reporter molecule.

3. A method of testing biomolecular interactions comprising:

a) generating a first fusion product comprising;

i) a first fragment of a first monomeric enzyme molecule and

ii) a second molecule which is different from said first molecule;

b) generating a second fusion product comprising

i) a second monomeric enzyme fragment of said first molecule; and

ii) a third molecule which is different from said first molecule or second molecule;

c) allowing the first and second fusion products to contact each other; and

d) testing for activity regained by association of the enzyme fragments of the first molecule, wherein said reassociation is mediated by interaction of the second and third molecules.

4. A method comprising an assay where fragments of a first monomeric enzyme molecule are fused to a second molecule and fragment association is detected by reconstitution of the first enzyme molecule'"'"'s activity.

5. A composition comprising a product selected from the group consisting of:

(a) a first fusion product comprising;

1) a first fragment of a first monomeric enzyme molecule whose fragments exhibit a detectable activity when associated and

2) a second molecule that is fused to said first fragment;

(b) a second fusion product comprising

1) a second fragment of said first monomeric enzyme molecule and

2) a third molecule that is fused to said second fragment; and

c) both (a) and (b).

6. A composition comprising complementary fragments of a first monomeric enzyme molecule that exhibits a detectable activity when associated, wherein each fragment is fused to a separate molecule.

7. A composition comprising a nucleic acid molecule coding for a enzyme fusion product, which molecule comprises sequences coding for a product selected from the group consisting of:

(a) a first enzyme fusion product comprising;

1) fragments of a first monomeric enzyme molecule whose fragments can exhibit a detectable activity when associated and

2) a second molecule fused to the fragment of the first molecule;

(b) a second fusion product comprising

1) a second fragment of said first monomeric enzyme molecule and

2) a second or third molecule; and

(c) both (a) and (b).

8. A method of testing for biomolecular interactions associated with:

(a) complementary fragments of a first monomeric enzyme molecule whose fragments can exhibit a detectable activity when associated, said method comprising;

1) creating a fusion of

(a) a first fragment of a first monomeric enzyme molecule whose fragments can exhibit a detectable activity when associated and

(b) a first protein-protein interacting domain;

2) creating a fusion of

(a) a second fragment of said first monomeric enzyme molecule and (b) a second or third protein-protein interacting domain that can bind said first protein-protein interacting domain;

3) allowing the fusions of (1) and (2) to contact each other; and

4) testing for reconstitution of said enzyme activity.

9. A composition comprising a product selected from the group consisting of:

(a) a first fusion product comprising;

1) a first fragment of a monomeric enzyme molecule whose fragments exhibit a detectable activity when associated and

2) a first protein-protein interacting domain;

(b) a second fusion product comprising

1) a second fragment of said first monomeric enzyme molecule and

2) a second protein-protein interacting domain that can bind said first protein-protein interacting domain; and

(c) both (a) and (b).

10. A composition comprising a nucleic acid molecule coding for an enzyme fusion product, which molecule comprises sequences coding for either:

(a) a first fusion product comprising;

1) a first fragment of a monomeric enzyme molecule whose fragments exhibit a detectable activity when associated and

2) a first protein-protein interacting domain;

or

(b) a second fusion product comprising

1) a second fragment of said monomeric enzyme molecule and

2) a second protein-protein interacting domain that can bind said first protein-protein interacting domain;

or

(c) both (a) and (b).

11. A method of screening a cDNA library comprising performing an enzyme complementation assay wherein said assay detection means is reconstitution of enzyme activity said enzyme being monomeric.

12. A method for detecting biomolecular interactions said method comprising:

(a) selecting an appropriate monomeric enzyme reporter molecule;

(b) effecting fragmentation of said monomeric enzyme reporter molecule;

(c) fusing or attaching fragments of said monomeric enzyme reporter molecule separately to other molecules;

followed by

(d) reassociation of said reporter fragments through interactions of the molecules that are fused to said fragments; and

(e) detecting said biomolecular interactions by reconstitution of enzyme activity.

13. A method for detecting biomolecular interactions said method comprising:

(a) selecting an appropriate reporter molecule selected from the group consisting of a monomeric enzyme, a fluorescent protein, a luminescent protein and a phosphorescent protein;

(b) effecting fragmentation of said reporter molecule such that said fragmentation results in reversible loss of reporter function;

(c) fusing or attaching fragments of said reporter molecule separately to other molecules;

followed by

(d) reassociation of said reporter fragments through interactions of the molecules that are fused to said fragments; and

(e) detecting said biomolecular interactions by reconstitution of activity of the reporter molecule.

14. Protein fragment complementation assays for the detection of molecular interactions comprising a reassembly of separate fragments of an enzyme having a molecular weight in the range of 10-40 KDa wherein reassembly of the enzyme fragments is operated by the interaction of molecular domains fused to each enzyme fragment, wherein reassembly of the enzyme fragments is independent of other molecular processes and wherein said reassembly is detected by means of reconstitution of activity of said enzyme.